RecruitingNot ApplicableNCT07332546

EOIB for Pain After Laparoscopic Cholecystectomy

External Oblique Intercostal Block for Postoperative Pain After Laparoscopic Cholecystectomy: A Randomized Controlled Trial


Sponsor

Shiyou Wei

Enrollment

56 participants

Start Date

Jan 15, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

This prospective, randomized, controlled, assessor-blinded trial will evaluate whether bilateral ultrasound-guided external oblique intercostal block (EOIB) reduces postoperative opioid consumption and improves pain control after laparoscopic cholecystectomy, compared with no block.


Eligibility

Min Age: 18 YearsMax Age: 85 Years

Inclusion Criteria4

  • Aged 18-85 years, regardless of gender
  • American Society of Anesthesiologists (ASA) physical status classification I-III
  • Scheduled for elective laparoscopic cholecystectomy
  • Ability to use the intravenous patient-controlled analgesia (IV PCA) system

Exclusion Criteria7

  • Hepatic disease (e.g., liver enzyme levels ≥ 2× the upper limit of normal)
  • Renal disease (e.g., serum creatinine levels ≥ 2× the upper limit of normal)
  • Allergy or known hypersensitivity to local anesthetics
  • Females who are pregnant or lactating
  • Conversion to open surgery
  • Coagulopathy or current use of anticoagulant medications
  • Opioid use for more than 2 weeks in the past 6 months

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERExternal oblique intercostal block (EOIB)

Bilateral ultrasound-guided external oblique intercostal block performed under sterile conditions after induction of general anesthesia and before surgical incision. Using an in-plane technique, the block is performed at the level of the 6th rib in the 6th-7th intercostal space. A local anesthetic mixture is injected with a total volume of 15 mL per side (prepared by mixing 0.75% ropivacaine with normal saline).

OTHERStandard care without regional block

Participants do not receive any regional anesthesia/nerve block (including external oblique intercostal block). All participants receive standard general anesthesia and the same standardized postoperative multimodal analgesia regimen as per protocol, including intravenous patient-controlled analgesia (PCA) with butorphanol.


Locations(1)

Tianmen First People's Hospital

Tianmen, Hubei, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07332546


Related Trials